<?xml version="1.0" encoding="UTF-8"?>
 <rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:cc="http://web.resource.org/cc/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/" xmlns:admin="http://webns.net/mvcb/">
  <channel rdf:about="http://pinboard.in">
    <title>Pinboard (aheilbut)</title>
    <link>https://pinboard.in/u:aheilbut/public/</link>
    <description>recent bookmarks from aheilbut</description>
    <items>
      <rdf:Seq>	<rdf:li rdf:resource="https://www.globaldata.com/industries-we-cover/pharmaceutical/"/>
	<rdf:li rdf:resource="https://info.evaluategroup.com/rs/607-YGS-364/images/WP17.pdf"/>
	<rdf:li rdf:resource="https://prospect.org/article/insulin-racket"/>
	<rdf:li rdf:resource="https://www.markmanadvisors.com/blog"/>
	<rdf:li rdf:resource="https://www.carlsoncaspers.com/anda-advisors-blog/"/>
	<rdf:li rdf:resource="https://www.forbes.com/sites/simonking/2013/07/15/the-best-selling-drugs-since-1996-why-abbvies-humira-is-set-to-eclipse-pfizers-lipitor/#6f915c8a6a8d"/>
	<rdf:li rdf:resource="https://www.aei.org/scholar/roger-bate/"/>
	<rdf:li rdf:resource="https://www.katherineeban.com/"/>
	<rdf:li rdf:resource="https://www.newyorker.com/magazine/2019/04/08/the-challenge-of-going-off-psychiatric-drugs"/>
	<rdf:li rdf:resource="https://www.aetion.com/"/>
	<rdf:li rdf:resource="https://m4kpharma.com/"/>
	<rdf:li rdf:resource="http://www.evaluate.com/vantage/articles/events/conferences/aha-2018-amarin-goes-hard-vascepa-questions-remain"/>
	<rdf:li rdf:resource="https://www.americanbar.org/groups/health_law/publications/aba_health_esource/2017-2018/may2018/granston/"/>
	<rdf:li rdf:resource="https://drugpricinglab.org/"/>
	<rdf:li rdf:resource="https://www.vikingtherapeutics.com/"/>
	<rdf:li rdf:resource="https://www.npr.org/sections/health-shots/2018/09/01/641615877/insulins-high-cost-leads-to-lethal-rationing"/>
	<rdf:li rdf:resource="https://www.bloomberg.com/view/articles/2018-08-17/cvs-drug-price-plan-lets-pharma-off-too-easy"/>
	<rdf:li rdf:resource="https://www.tracelink.com/"/>
	<rdf:li rdf:resource="https://www.nytimes.com/2018/08/18/us/politics/states-drug-costs.html"/>
	<rdf:li rdf:resource="https://www.bloomberg.com/news/features/2018-04-06/when-these-new-pharma-bros-show-up-drug-prices-tend-to-go-monumentally-higher"/>
	<rdf:li rdf:resource="https://www.wsj.com/articles/drug-price-hike-sparks-senate-probe-1522677600?redirect=amp"/>
	<rdf:li rdf:resource="https://www.forbes.com/sites/matthewherper/2017/10/16/the-cost-of-developing-drugs-is-insane-a-paper-that-argued-otherwise-was-insanely-bad/#3d2148202d45"/>
	<rdf:li rdf:resource="https://techcrunch.com/2017/01/06/this-millennial-wants-to-build-the-berkshire-hathaway-of-biopharmaceutical-companies-can-he-pull-it-off/"/>
	<rdf:li rdf:resource="http://www.nature.com.ezproxy.bu.edu/nrd/journal/v16/n1/full/nrd.2016.236.html"/>
	<rdf:li rdf:resource="https://www.drugpatentwatch.com/"/>
	<rdf:li rdf:resource="http://www.numerate.com/company/"/>
	<rdf:li rdf:resource="https://www.propublica.org/article/when-a-study-cast-doubt-on-heart-pill-the-drug-company-turned-to-tom-price"/>
	<rdf:li rdf:resource="http://www.pharmaskeletons.com/"/>
	<rdf:li rdf:resource="https://www.opentargets.org/"/>
	<rdf:li rdf:resource="http://www.nytimes.com/2016/02/21/opinion/sunday/break-up-the-insulin-racket.html"/>
	<rdf:li rdf:resource="http://drugbaron.com/"/>
	<rdf:li rdf:resource="http://www.recursionpharma.com/"/>
	<rdf:li rdf:resource="http://theweek.com/articles/541564/how-american-opiate-epidemic-started-by-pharmaceutical-company"/>
	<rdf:li rdf:resource="http://www.motherjones.com/environment/2015/04/dan-markingson-university-minnesota-clinical-trials-astrazeneca"/>
	<rdf:li rdf:resource="http://www.nytimes.com/2014/04/27/sunday-review/it-will-save-lives-but-whats-the-cost.html?hp&amp;rref=opinion"/>
	<rdf:li rdf:resource="http://www.drugpatentwatch.com/"/>
	<rdf:li rdf:resource="http://www.newyorker.com/talk/financial/2014/04/28/140428ta_talk_surowiecki"/>
	<rdf:li rdf:resource="http://www.motherjones.com/politics/2013/08/meth-pseudoephedrine-big-pharma-lobby"/>
	<rdf:li rdf:resource="http://features.blogs.fortune.cnn.com/2013/05/15/ranbaxy-fraud-lipitor/"/>
	<rdf:li rdf:resource="http://keionline.org/prices/sources"/>
	<rdf:li rdf:resource="http://www.scientificamerican.com/article.cfm?id=how-drug-company-money-undermining-science&amp;print=true"/>
	<rdf:li rdf:resource="http://www.recap.com/index.html"/>
	<rdf:li rdf:resource="http://www.liaad.up.pt/ida2011/videoBerthold.html"/>
	<rdf:li rdf:resource="http://www.nuevolution.com/index.htm"/>
	<rdf:li rdf:resource="http://online.wsj.com/article/SB10001424052748703627704575298783153884208.html?mod=igoogle_wsj_gadgv1&amp;#articleTabs_comments"/>
	<rdf:li rdf:resource="http://blogs.wsj.com/health/2009/02/19/how-to-lure-clinical-trials-back-to-the-us/tab/article/"/>
	<rdf:li rdf:resource="http://pharmtech.findpharma.com/pharmtech/Regulation+Article/A-Call-for-Transparency-in-Research-and-Marketing/ArticleStandard/Article/detail/584966"/>
	<rdf:li rdf:resource="http://www.frankel-group.com/"/>
	<rdf:li rdf:resource="http://www.steeprockinc.com/"/>
	<rdf:li rdf:resource="http://online.barrons.com/article/SB121340684461474167.html?mod=b_hps_9_0001_b_this_weeks_magazine_home_right"/>
	<rdf:li rdf:resource="http://www.wuxipharmatech.com/about/index.asp"/>
	<rdf:li rdf:resource="http://www.stats.org/"/>
	<rdf:li rdf:resource="http://www.brandweeknrx.com/"/>
	<rdf:li rdf:resource="http://pipeline.corante.com/"/>
	<rdf:li rdf:resource="http://www.google.com/search?q=pharmaceutical+authentication&amp;start=0&amp;ie=utf-8&amp;oe=utf-8&amp;client=firefox-a&amp;rls=org.mozilla:en-US:official"/>
	<rdf:li rdf:resource="http://www.pharmagrowth.com/Partners.html"/>
      </rdf:Seq>
    </items>
  </channel><item rdf:about="https://www.globaldata.com/industries-we-cover/pharmaceutical/">
    <title>Pharmaceutical - GlobalData</title>
    <dc:date>2022-01-05T05:45:47+00:00</dc:date>
    <link>https://www.globaldata.com/industries-we-cover/pharmaceutical/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma data</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:e6122589f6c6/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:data"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://info.evaluategroup.com/rs/607-YGS-364/images/WP17.pdf">
    <title>Welcome to the EvaluatePharma® World Preview 2017, Outlook to 2022</title>
    <dc:date>2019-12-12T21:17:57+00:00</dc:date>
    <link>https://info.evaluategroup.com/rs/607-YGS-364/images/WP17.pdf</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma market analysis</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:51212437d764/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:market"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:analysis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://prospect.org/article/insulin-racket">
    <title>The Insulin Racket</title>
    <dc:date>2019-06-25T15:25:24+00:00</dc:date>
    <link>https://prospect.org/article/insulin-racket</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>insulin pharma pricing</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:65c7bc796441/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:insulin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pricing"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.markmanadvisors.com/blog">
    <title>Blog — Markman Advisors</title>
    <dc:date>2019-06-06T17:27:25+00:00</dc:date>
    <link>https://www.markmanadvisors.com/blog</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>patents pharma IP</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:54a1da13e5b8/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:patents"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:IP"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.carlsoncaspers.com/anda-advisors-blog/">
    <title>ANDA Advisors Blog - Carlson Caspers IP Litigation &amp; Counseling</title>
    <dc:date>2019-06-06T17:18:24+00:00</dc:date>
    <link>https://www.carlsoncaspers.com/anda-advisors-blog/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>ANDA litigation IP pharma generics</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:b2b79ad94f55/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:ANDA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:litigation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:IP"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:generics"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.forbes.com/sites/simonking/2013/07/15/the-best-selling-drugs-since-1996-why-abbvies-humira-is-set-to-eclipse-pfizers-lipitor/#6f915c8a6a8d">
    <title>The Best Selling Drugs Since 1996 - Why AbbVie's Humira Is Set To Eclipse Pfizer's Lipitor</title>
    <dc:date>2019-05-29T21:16:03+00:00</dc:date>
    <link>https://www.forbes.com/sites/simonking/2013/07/15/the-best-selling-drugs-since-1996-why-abbvies-humira-is-set-to-eclipse-pfizers-lipitor/#6f915c8a6a8d</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma sales</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:debc6a6dc664/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:sales"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.aei.org/scholar/roger-bate/">
    <title>Roger Bate | AEI Scholar</title>
    <dc:date>2019-05-27T01:43:27+00:00</dc:date>
    <link>https://www.aei.org/scholar/roger-bate/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>people drugs pharma</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:7953d4a9629f/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:people"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:drugs"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.katherineeban.com/">
    <title>Bottle of Lies</title>
    <dc:date>2019-05-26T22:35:52+00:00</dc:date>
    <link>https://www.katherineeban.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>journalists healthcare pharma generics</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:9c3b597abd84/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:journalists"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:healthcare"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:generics"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.newyorker.com/magazine/2019/04/08/the-challenge-of-going-off-psychiatric-drugs">
    <title>The Challenge of Going Off Psychiatric Drugs | The New Yorker</title>
    <dc:date>2019-04-01T18:12:52+00:00</dc:date>
    <link>https://www.newyorker.com/magazine/2019/04/08/the-challenge-of-going-off-psychiatric-drugs</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>psychiatry pharma psychopharmacology</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:80b43aa00c0c/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:psychiatry"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:psychopharmacology"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.aetion.com/">
    <title>Aetion</title>
    <dc:date>2019-03-21T15:46:07+00:00</dc:date>
    <link>https://www.aetion.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>evidence pharma epidemiology</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:eb787e027dfe/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:evidence"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:epidemiology"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://m4kpharma.com/">
    <title>M4K Pharma – Open Science for Children's Health</title>
    <dc:date>2019-01-23T16:24:27+00:00</dc:date>
    <link>https://m4kpharma.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma open glioma models alededwards toronto</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:5536cc1ad1ed/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:open"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:glioma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:models"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:alededwards"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:toronto"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.evaluate.com/vantage/articles/events/conferences/aha-2018-amarin-goes-hard-vascepa-questions-remain">
    <title>AHA 2018 – Amarin goes hard on Vascepa but questions remain | Evaluate</title>
    <dc:date>2018-11-19T06:35:15+00:00</dc:date>
    <link>http://www.evaluate.com/vantage/articles/events/conferences/aha-2018-amarin-goes-hard-vascepa-questions-remain</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>biotech pharma</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:5dd67e3dd287/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:biotech"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.americanbar.org/groups/health_law/publications/aba_health_esource/2017-2018/may2018/granston/">
    <title>The DOJ’s Granston memo encourages dismissal of meritless qui tam cases</title>
    <dc:date>2018-11-13T17:17:05+00:00</dc:date>
    <link>https://www.americanbar.org/groups/health_law/publications/aba_health_esource/2017-2018/may2018/granston/</link>
    <dc:creator>aheilbut</dc:creator><description><![CDATA[Whether the Memo will have an effect on how the DOJ handles future FCA qui tam cases remains to be seen. The Memo may, however, offer defendants some guidance on how to urge the DOJ to dismiss under Section 3730(c)(2)(A) after the DOJ has declined to intervene in a qui tam relator’s case. It may also help potential relators assess whether and how to proceed.

]]></description>
<dc:subject>FCA law pharma fraud</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:62fdc2d5cf6b/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:FCA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:law"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:fraud"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://drugpricinglab.org/">
    <title>Home - Drug Pricing Lab</title>
    <dc:date>2018-10-04T19:33:42+00:00</dc:date>
    <link>https://drugpricinglab.org/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pricing pharma ethics economics</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:60f63076b1c8/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pricing"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:ethics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:economics"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.vikingtherapeutics.com/">
    <title>Viking Therapeutics</title>
    <dc:date>2018-09-18T20:26:51+00:00</dc:date>
    <link>https://www.vikingtherapeutics.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>NASH pharma</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:3fd76ac65e77/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:NASH"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.npr.org/sections/health-shots/2018/09/01/641615877/insulins-high-cost-leads-to-lethal-rationing">
    <title>High Price Of Insulin Leads Patients To Ration The Drug. That Can Be Lethal : Shots - Health News : NPR</title>
    <dc:date>2018-09-02T23:25:16+00:00</dc:date>
    <link>https://www.npr.org/sections/health-shots/2018/09/01/641615877/insulins-high-cost-leads-to-lethal-rationing</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma pricing insulin</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:6b1acac68544/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pricing"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:insulin"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.bloomberg.com/view/articles/2018-08-17/cvs-drug-price-plan-lets-pharma-off-too-easy">
    <title>CVS Drug-Price Plan Lets Pharma Off Too Easy - Bloomberg</title>
    <dc:date>2018-08-22T18:53:08+00:00</dc:date>
    <link>https://www.bloomberg.com/view/articles/2018-08-17/cvs-drug-price-plan-lets-pharma-off-too-easy</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pan pharma kickbacks</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:cbdd3749c8cc/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pan"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:kickbacks"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.tracelink.com/">
    <title>Track &amp; Trace Solutions | Serialization Compliance | TraceLink</title>
    <dc:date>2018-08-21T20:09:18+00:00</dc:date>
    <link>https://www.tracelink.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>supplychain tracking pharma serialization</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:8cef1ebc83db/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:supplychain"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:tracking"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:serialization"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.nytimes.com/2018/08/18/us/politics/states-drug-costs.html">
    <title>States Rush to Rein In Prescription Costs, and Drug Companies Fight Back - The New York Times</title>
    <dc:date>2018-08-20T22:31:03+00:00</dc:date>
    <link>https://www.nytimes.com/2018/08/18/us/politics/states-drug-costs.html</link>
    <dc:creator>aheilbut</dc:creator><description><![CDATA[States Rush to Rein In Prescription Costs, and Drug Companies Fight Back, via @NYTimes ]]></description>
<dc:subject>pharma drugpricing</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:585c747a2c59/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:drugpricing"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.bloomberg.com/news/features/2018-04-06/when-these-new-pharma-bros-show-up-drug-prices-tend-to-go-monumentally-higher">
    <title>Prescription Drug Prices Often Spike When This Duo Shows Up - Bloomberg</title>
    <dc:date>2018-04-08T12:27:01+00:00</dc:date>
    <link>https://www.bloomberg.com/news/features/2018-04-06/when-these-new-pharma-bros-show-up-drug-prices-tend-to-go-monumentally-higher</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma pricing</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:dc88431060d6/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pricing"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.wsj.com/articles/drug-price-hike-sparks-senate-probe-1522677600?redirect=amp">
    <title>Drug Price Hike Sparks Senate Probe - WSJ</title>
    <dc:date>2018-04-02T23:44:52+00:00</dc:date>
    <link>https://www.wsj.com/articles/drug-price-hike-sparks-senate-probe-1522677600?redirect=amp</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma pricing</dc:subject>
<dc:identifier>https://pinboard.in/u:aheilbut/b:d2ed47486eff/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pricing"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.forbes.com/sites/matthewherper/2017/10/16/the-cost-of-developing-drugs-is-insane-a-paper-that-argued-otherwise-was-insanely-bad/#3d2148202d45">
    <title>The Cost Of Developing Drugs Is Insane. That Paper That Says Otherwise Is Insanely Bad</title>
    <dc:date>2017-10-16T22:07:50+00:00</dc:date>
    <link>https://www.forbes.com/sites/matthewherper/2017/10/16/the-cost-of-developing-drugs-is-insane-a-paper-that-argued-otherwise-was-insanely-bad/#3d2148202d45</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma R&amp;D costs healthcare</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:53cd1a5608b9/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:R&amp;D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:costs"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:healthcare"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://techcrunch.com/2017/01/06/this-millennial-wants-to-build-the-berkshire-hathaway-of-biopharmaceutical-companies-can-he-pull-it-off/">
    <title>The billion-dollar pharma startup that Silicon Valley has totally missed | TechCrunch</title>
    <dc:date>2017-04-24T18:14:43+00:00</dc:date>
    <link>https://techcrunch.com/2017/01/06/this-millennial-wants-to-build-the-berkshire-hathaway-of-biopharmaceutical-companies-can-he-pull-it-off/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>roivant axon pharma</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:a13b79c5f720/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:roivant"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:axon"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.nature.com.ezproxy.bu.edu/nrd/journal/v16/n1/full/nrd.2016.236.html">
    <title>Drug launch curves in the modern era : Nature Reviews Drug Discovery : Nature Research</title>
    <dc:date>2017-04-17T02:40:56+00:00</dc:date>
    <link>http://www.nature.com.ezproxy.bu.edu/nrd/journal/v16/n1/full/nrd.2016.236.html</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma launchcurves</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:7a199c6e17e1/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:launchcurves"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.drugpatentwatch.com/">
    <title>Pharmaceutical business intelligence: International drug patent expirations, generic manufacturers, suppliers, formulation</title>
    <dc:date>2017-04-16T17:11:14+00:00</dc:date>
    <link>https://www.drugpatentwatch.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>patents pharma</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:19554514fa10/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:patents"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.numerate.com/company/">
    <title>Company - Numerate</title>
    <dc:date>2017-03-13T19:19:34+00:00</dc:date>
    <link>http://www.numerate.com/company/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma ml pharmix biotech companies</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:526e9e73fae4/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:ml"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharmix"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:biotech"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:companies"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.propublica.org/article/when-a-study-cast-doubt-on-heart-pill-the-drug-company-turned-to-tom-price">
    <title>When a Study Cast Doubt on a Heart Pill, the Drug Company Turned to Tom Price - ProPublica</title>
    <dc:date>2017-01-25T02:01:58+00:00</dc:date>
    <link>https://www.propublica.org/article/when-a-study-cast-doubt-on-heart-pill-the-drug-company-turned-to-tom-price</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma trump price</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:12e96cc32d5b/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:trump"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:price"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.pharmaskeletons.com/">
    <title>Pharma Skeletons</title>
    <dc:date>2017-01-23T23:24:08+00:00</dc:date>
    <link>http://www.pharmaskeletons.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma shkreli</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:b9a0a79eb064/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:shkreli"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.opentargets.org/">
    <title>Home | Open Targets</title>
    <dc:date>2016-06-28T12:26:48+00:00</dc:date>
    <link>https://www.opentargets.org/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>targets collaboration pharma</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:5f3e62d2ff12/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:targets"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:collaboration"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.nytimes.com/2016/02/21/opinion/sunday/break-up-the-insulin-racket.html">
    <title>Break Up the Insulin Racket - The New York Times</title>
    <dc:date>2016-02-23T03:30:33+00:00</dc:date>
    <link>http://www.nytimes.com/2016/02/21/opinion/sunday/break-up-the-insulin-racket.html</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma insulin drugpricing</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:b63be9aeeb66/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:insulin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:drugpricing"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://drugbaron.com/">
    <title>Drug Baron | Drug Baron – news and opinions on life sciences from leading uk consultancy</title>
    <dc:date>2015-06-19T05:31:46+00:00</dc:date>
    <link>http://drugbaron.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>blog biotech pharma</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:186d693a5d45/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:blog"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:biotech"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.recursionpharma.com/">
    <title>Recursion Pharmaceuticals - Home</title>
    <dc:date>2015-06-08T15:30:24+00:00</dc:date>
    <link>http://www.recursionpharma.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma repurposing</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:1e672c65f2a9/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:repurposing"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://theweek.com/articles/541564/how-american-opiate-epidemic-started-by-pharmaceutical-company">
    <title>How the American opiate epidemic was started by one pharmaceutical company</title>
    <dc:date>2015-05-28T02:52:51+00:00</dc:date>
    <link>http://theweek.com/articles/541564/how-american-opiate-epidemic-started-by-pharmaceutical-company</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>oxycontin opiates purdue pharma</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:33f4ed5cf4ca/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:oxycontin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:opiates"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:purdue"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.motherjones.com/environment/2015/04/dan-markingson-university-minnesota-clinical-trials-astrazeneca">
    <title>University of Minnesota Blasted for Deadly Clinical Trial | Mother Jones</title>
    <dc:date>2015-04-04T05:29:58+00:00</dc:date>
    <link>http://www.motherjones.com/environment/2015/04/dan-markingson-university-minnesota-clinical-trials-astrazeneca</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma trials ethics</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:e37baca1b2b4/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:trials"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:ethics"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.nytimes.com/2014/04/27/sunday-review/it-will-save-lives-but-whats-the-cost.html?hp&amp;rref=opinion">
    <title>For Drugs That Save Lives, a Steep Cost - NYTimes.com</title>
    <dc:date>2014-04-27T20:06:46+00:00</dc:date>
    <link>http://www.nytimes.com/2014/04/27/sunday-review/it-will-save-lives-but-whats-the-cost.html?hp&amp;rref=opinion</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma pricing</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:85e4da9205ee/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pricing"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.drugpatentwatch.com/">
    <title>DrugPatentWatch.com | Pharmaceutical drugs, patents, branded and generic manufacturers, and suppliers</title>
    <dc:date>2014-04-26T23:43:53+00:00</dc:date>
    <link>http://www.drugpatentwatch.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>patents pharma</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:048cee8cbc68/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:patents"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.newyorker.com/talk/financial/2014/04/28/140428ta_talk_surowiecki">
    <title>James Surowiecki: Should We Regulate Drug Prices? : The New Yorker</title>
    <dc:date>2014-04-23T00:02:35+00:00</dc:date>
    <link>http://www.newyorker.com/talk/financial/2014/04/28/140428ta_talk_surowiecki</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>sovaldi gilead pricing pharma</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:b4d6f75c454a/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:sovaldi"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:gilead"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pricing"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.motherjones.com/politics/2013/08/meth-pseudoephedrine-big-pharma-lobby">
    <title>Merchants of Meth: How Big Pharma Keeps the Cooks in Business | Mother Jones</title>
    <dc:date>2013-10-01T02:44:34+00:00</dc:date>
    <link>http://www.motherjones.com/politics/2013/08/meth-pseudoephedrine-big-pharma-lobby</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>meth drugs pharma bigpharma badpharma</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:0249d9bee368/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:meth"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:drugs"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:bigpharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:badpharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://features.blogs.fortune.cnn.com/2013/05/15/ranbaxy-fraud-lipitor/">
    <title>Dirty medicine - Fortune Features</title>
    <dc:date>2013-05-16T03:14:30+00:00</dc:date>
    <link>http://features.blogs.fortune.cnn.com/2013/05/15/ranbaxy-fraud-lipitor/</link>
    <dc:creator>aheilbut</dc:creator><description><![CDATA[RT @dgmacarthur: Terrifying piece about rampant fraud in a generic drug manufacturer, and the weak FDA response: ]]></description>
<dc:subject>ranbaxy fraud pharma malfeasance trust fda</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:77717f19b67c/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:ranbaxy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:fraud"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:malfeasance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:trust"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:fda"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://keionline.org/prices/sources">
    <title>Sources for Researching Drug Prices | Knowledge Ecology International</title>
    <dc:date>2013-01-09T17:20:02+00:00</dc:date>
    <link>http://keionline.org/prices/sources</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma pricing</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:fe6e86ab4a90/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pricing"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.scientificamerican.com/article.cfm?id=how-drug-company-money-undermining-science&amp;print=true">
    <title>How Drug Company Money is Undermining Science: Scientific American</title>
    <dc:date>2012-11-21T15:07:06+00:00</dc:date>
    <link>http://www.scientificamerican.com/article.cfm?id=how-drug-company-money-undermining-science&amp;print=true</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>research pharma transparency</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:0fd7279c6411/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:transparency"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.recap.com/index.html">
    <title>Deloitte Recap LLC</title>
    <dc:date>2012-07-17T23:49:00+00:00</dc:date>
    <link>http://www.recap.com/index.html</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>recap pharma database</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:035e5a25b299/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:recap"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:database"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.liaad.up.pt/ida2011/videoBerthold.html">
    <title>IDA 2011 — The Tenth International Symposium on Intelligent Data Analysis</title>
    <dc:date>2012-02-19T05:15:42+00:00</dc:date>
    <link>http://www.liaad.up.pt/ida2011/videoBerthold.html</link>
    <dc:creator>aheilbut</dc:creator><description><![CDATA[interesting looking talk by michael berthold; prof in germany who developed Knime and used to work in pharma]]></description>
<dc:subject>knime pharma analytics</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:bb26b989d8f4/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:knime"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:analytics"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.nuevolution.com/index.htm">
    <title>Welcome to Nuevolution</title>
    <dc:date>2012-02-19T05:05:17+00:00</dc:date>
    <link>http://www.nuevolution.com/index.htm</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>chemistry pharma evolutionarychemistry evolution</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:aheilbut/b:6beb19575edf/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:chemistry"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:evolutionarychemistry"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:evolution"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://online.wsj.com/article/SB10001424052748703627704575298783153884208.html?mod=igoogle_wsj_gadgv1&amp;#articleTabs_comments">
    <title>Drug Makers Share Data From Failed Trials - WSJ.com</title>
    <dc:date>2010-06-13T01:22:55+00:00</dc:date>
    <link>http://online.wsj.com/article/SB10001424052748703627704575298783153884208.html?mod=igoogle_wsj_gadgv1&amp;#articleTabs_comments</link>
    <dc:creator>aheilbut</dc:creator><description><![CDATA[A group of major pharmaceutical companies will share pooled data from failed clinical trials in an attempt to figure out what is going wrong in the studies and what can be done to improve drug development.
The data will be available to all the participating drug makers, as well as outside researchers with a valid scientific question, Dr. Cantillon said.
]]></description>
<dc:subject>pharma collaboration transparency fda</dc:subject>
<dc:identifier>https://pinboard.in/u:aheilbut/b:cc99f0beace8/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:collaboration"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:transparency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:fda"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://blogs.wsj.com/health/2009/02/19/how-to-lure-clinical-trials-back-to-the-us/tab/article/">
    <title>How to Lure Clinical Trials Back to the U.S. - Health Blog - WSJ</title>
    <dc:date>2010-03-16T16:31:26+00:00</dc:date>
    <link>http://blogs.wsj.com/health/2009/02/19/how-to-lure-clinical-trials-back-to-the-us/tab/article/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>clinicaltrials pharma</dc:subject>
<dc:identifier>https://pinboard.in/u:aheilbut/b:55f8497aab22/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:clinicaltrials"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation+Article/A-Call-for-Transparency-in-Research-and-Marketing/ArticleStandard/Article/detail/584966">
    <title>A Call for Transparency in Research and Marketing - Pharmaceutical Technology</title>
    <dc:date>2010-03-16T16:30:28+00:00</dc:date>
    <link>http://pharmtech.findpharma.com/pharmtech/Regulation+Article/A-Call-for-Transparency-in-Research-and-Marketing/ArticleStandard/Article/detail/584966</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>transparency pharma</dc:subject>
<dc:identifier>https://pinboard.in/u:aheilbut/b:dc96b4760c7c/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:transparency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.frankel-group.com/">
    <title>Frankel Group</title>
    <dc:date>2009-08-20T01:28:31+00:00</dc:date>
    <link>http://www.frankel-group.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>consulting companies pharma</dc:subject>
<dc:identifier>https://pinboard.in/u:aheilbut/b:f48b5c47eb70/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:consulting"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:companies"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.steeprockinc.com/">
    <title>Welcome! | SteepRock Inc.</title>
    <dc:date>2009-01-26T20:54:38+00:00</dc:date>
    <link>http://www.steeprockinc.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>companies pharma opinionleaders optimization</dc:subject>
<dc:identifier>https://pinboard.in/u:aheilbut/b:001d8333a366/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:companies"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:opinionleaders"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:optimization"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://online.barrons.com/article/SB121340684461474167.html?mod=b_hps_9_0001_b_this_weeks_magazine_home_right">
    <title>The Squeeze on Shire - Barrons.com</title>
    <dc:date>2008-06-15T03:26:44+00:00</dc:date>
    <link>http://online.barrons.com/article/SB121340684461474167.html?mod=b_hps_9_0001_b_this_weeks_magazine_home_right</link>
    <dc:creator>aheilbut</dc:creator><description><![CDATA[Shire's dependence on a drug for attention-deficit disorder that's scheduled to lose patent protection in April is tough a enough for pill for the British drug maker's holders to swallow. FDA decisions could inflict even more pain on the stock]]></description>
<dc:subject>shire patent expiration pharma</dc:subject>
<dc:identifier>https://pinboard.in/u:aheilbut/b:ca3e262832c1/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:shire"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:patent"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:expiration"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.wuxipharmatech.com/about/index.asp">
    <title>WuXi PharmaTech</title>
    <dc:date>2007-08-09T21:29:58+00:00</dc:date>
    <link>http://www.wuxipharmatech.com/about/index.asp</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>outsourcing pharma companies WX</dc:subject>
<dc:identifier>https://pinboard.in/u:aheilbut/b:6cad35ebb96e/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:outsourcing"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:companies"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:WX"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.stats.org/">
    <title>STATS.org - home page</title>
    <dc:date>2007-07-29T07:26:20+00:00</dc:date>
    <link>http://www.stats.org/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>statistics stats journalism pharma</dc:subject>
<dc:identifier>https://pinboard.in/u:aheilbut/b:0241c51f0a12/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:statistics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:stats"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:journalism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.brandweeknrx.com/">
    <title>BrandweekNRX</title>
    <dc:date>2007-07-18T23:06:43+00:00</dc:date>
    <link>http://www.brandweeknrx.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma blog</dc:subject>
<dc:identifier>https://pinboard.in/u:aheilbut/b:9ad22db6912c/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:blog"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://pipeline.corante.com/">
    <title>In the Pipeline:</title>
    <dc:date>2007-05-24T07:41:55+00:00</dc:date>
    <link>http://pipeline.corante.com/</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>biotech blog pharma</dc:subject>
<dc:identifier>https://pinboard.in/u:aheilbut/b:4e9904ffe6a8/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:biotech"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:blog"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.google.com/search?q=pharmaceutical+authentication&amp;start=0&amp;ie=utf-8&amp;oe=utf-8&amp;client=firefox-a&amp;rls=org.mozilla:en-US:official">
    <title>pharmaceutical authentication - Google Search</title>
    <dc:date>2006-09-14T16:26:58+00:00</dc:date>
    <link>http://www.google.com/search?q=pharmaceutical+authentication&amp;start=0&amp;ie=utf-8&amp;oe=utf-8&amp;client=firefox-a&amp;rls=org.mozilla:en-US:official</link>
    <dc:creator>aheilbut</dc:creator><dc:subject>pharma counterfeit</dc:subject>
<dc:identifier>https://pinboard.in/u:aheilbut/b:eae8fc89f0ea/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:counterfeit"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.pharmagrowth.com/Partners.html">
    <title>Pharma Growth Strategies LLC - Our Partners</title>
    <dc:date>2006-05-21T03:40:17+00:00</dc:date>
    <link>http://www.pharmagrowth.com/Partners.html</link>
    <dc:creator>aheilbut</dc:creator><description><![CDATA[Specialized management consulting to the pharmaceutical and biotech industries. Areas of expertise include Business Development, Research and Development, Strategic Marketing and Lifecycle Management.]]></description>
<dc:subject>consulting biotech pharma</dc:subject>
<dc:identifier>https://pinboard.in/u:aheilbut/b:bbbb0cc98b99/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:consulting"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:biotech"/>
	<rdf:li rdf:resource="https://pinboard.in/u:aheilbut/t:pharma"/>
</rdf:Bag></taxo:topics>
</item>
</rdf:RDF>